Studies have found that c-Abl oncogenic kinases may regulate gene transcription by RNA polymerase II phosphorylation or by direct regulation of specific transcription factors or coactivators. However, the global regulation of differential gene expression by c-Abl/Arg is largely unknown. In this study, differentially expressed genes (DEGs) regulated by c-Abl/Arg were identified, and related cellular functions and associated pathways were investigated.
Background c-Abl was initially discovered as a homologous oncogene of the Abelson murine leukemia virus and implicated in chromosomal translocations in human leukemia [1] [2] [3] . The N-terminal structure of c-Abl contains Src homology 2 (SH2), SH3, and kinase domains [1, 4] , and the C-terminus has a DNA binding motif and a nuclear localization signal (NLS) for the nuclear localization of c-Abl [5, 6] . Arg (a c-Abl-related gene) shares ~90% homology with c-Abl at the N-terminus, implying that they share overlapping functions in cell growth [7] , apoptosis [8, 9] , response to DNA damage [10, 11] , and tumorigenesis [12, 13] . Activation of c-Abl/Arg has been detected in many solid tumors, including breast, lung, prostate, and colon carcinoma [14] [15] [16] [17] [18] [19] .
In contrast to other tyrosine kinases, c-Abl binds to DNA. Although early studies determined that c-Abl preferentially interacts with A/T-rich DNA or AAC motif-containing sequences, the specific DNA sequence and the related function of the c-Abl-DNA interaction were not clearly identified until recently. The high mobility group-like boxes (HLBs) of c-Abl prefer to bind bent or bendable DNA [20] , and c-Abl mainly contacts the minor groove of the double helix or strongly interacts with distorted DNA structures [21] . Kipreos et al. also reported that the hyperphosphorylation of the c-Abl DNA binding domain inactivates its DNA binding activity when cells enter mitosis, implying that c-Abl may play a role in cell cycle progression by transcriptional regulation [6, 22] . The C-terminal repeated domain (CTD) of RNA polymerase II (RNAPII) has been identified as the nuclear substrate of c-Abl [23] . Tyrosine phosphorylation of the consensus sequence YSPTSPS disrupts the recruitment of CTD-binding proteins [24] , by which c-Abl is likely to regulate RNA processing and chromatin modification globally. Moreover, c-Abl is also involved in specific gene transcription by targeting many transcription factors or regulators, such as p53, p73, NF-kB, c-Myc, C/EBPb, or Yap [25] [26] [27] [28] [29] [30] , during numerous biological processes. These findings collectively indicate that c-Abl/Arg plays an important role in gene transcription regulation.
To comprehensively study c-Abl/Arg-related transcription regulation, RNA was prepared from MCF-7/Scr and MCF-7/c-Abl/ Arg-knockdown cells and was subjected to RNA-Seq analysis. The differentially expressed genes (DEGs) were identified by comparing the RNA from MCF-7/Scr cells with that from MCF-7/c-Abl/Arg-knockdown cells, and GO and KEGG analyses of the DEGs suggested that c-Abl/Arg may play critical roles in multiple cellular processes by regulating gene transcription.
Material and Methods
Cell culture and c-Abl/Arg-targeting gene silencing All cells were grown in Dulbecco's Modified Eagle Medium (DMEM, Gibco) supplemented with 10% heat-inactivated fetal bovine serum (HyClone), 2 mM L-glutamine, 100 mg/ml streptomycin and 100 units/ml penicillin at 37°C. The siRNA sequence targeting the c-Abl/Arg mRNA was 5'-GGGAAATTGCTACCTATGG-3' (100% homology between cAbl and Arg). These primers were cloned into the psiSTRIK-ETM-Hygromycin vector (Promega, Madison, WI, USA). To obtain MCF-7/c-Abl/Arg-knockdown cell line, wild-type MCF-7 cells were transfected with the c-Abl/Arg-targeted siRNA plasmids using Lipofectamine 2000 DNA Transfection Reagent (Invitrogen) when the cells reached 50-70% confluence. At 36 h after transfection, the cells were maintained in DMEM with 50 mg/ml hygromycin B until individual clones were obtained. To evaluate siRNA efficacy, qRT-PCR and western blotting were performed to detect the mRNA and protein levels of c-Abl and Arg, respectively.
The scrambling gene silencing
The scrambling gene silencing cell line was established and used as a control of c-Abl/Arg-targeting gene silencing cell line. The scrambled siRNA sequence was 5'-GTGACATAGCAGGAACTAC-3', corresponding to a negative siRNA control with no match with any Homo sapiens mRNA sequences. The primers were cloned into the psiSTRIKETM-Hygromycin Vector (Promega, Madison, WI, USA). The MCF-7/Scramble cell line was established by the same method used in the MCF-7/c-Abl/Arg-knockdown cell line.
Quantitative real-time polymerase chain reaction analysis
Total RNA was extracted from the MCF-7/Scr and MCF-7/cAbl/Arg-knockdown cells using the RNeasy Mini Kit (QIAGEN). The total RNA was then used for cDNA synthesis with the GoScriptTM Reverse Transcription System (Promega) according to the manufacturer's protocol. qRT-PCR was performed using PowerUpTM SYBRTM Green Master Mix (Thermo Fisher), and the primer sequences are shown in Table 1 . The relative expression of the target genes was calculated according to the 2 -DDCT method and was normalized to the actin gene.
Western blot analysis
Cell lysates were prepared in lysis buffer (50 mM Tris-HCl [pH 7.5], 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 10 mM sodium fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin, and 10 µg/ml pepstatin A) containing 1% Nonidet P-40 and were then subjected to SDS-PAGE and blotted onto a transfer membrane (Millipore). Anti-c-Abl (Santa Cruz SC-131),
anti-Arg (Santa Cruz SC-20708), and anti-b-actin (Santa Cruz SC-1616) antibodies were used for the immunoblotting analysis. The antigen-antibody complexes were visualized by chemiluminescence (PerkinElmer Life Sciences).
Preparation of libraries and RNA sequencing
Total RNA was extracted from the 2 cell lines, and the quality and quantity of the RNA were determined by measuring the absorbance at 260 nm and 280 nm (A260/A280) using a SmartSpec Plus (Bio-Rad). The RNA integrity was further determined by 1.5% agarose gel electrophoresis. For each sample, 10 µg of total RNA was used to prepare the RNA-Seq libraries. Polyadenylated mRNAs were purified and concentrated with oligo(dT)-conjugated magnetic beads (Thermo Fisher), and reverse transcription was performed with primers harboring a 3' adaptor sequence and randomized hexamers. PCR products of cDNA corresponding to 200-500 bp were purified, quantified and stored at −80°C until sequencing.
High-throughput sequencing was performed on the Illumina HiSeq 2000 system by ABLife lnc. (Wuhan, China). A FASTXToolkit (Version 0.0.13) was used to obtain clean reads, and the raw sequencing data were also evaluated using FAST-QC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc).
Parameters such as quality distribution of nucleotides, position-specific sequencing quality, GC content, proportion of PCR duplication, and k-mer frequency were evaluated to obtain a deeper understanding of the data prior to variant evaluation.
Analysis of DEGs
According to the genome annotation, uniquely localized reads were used for the DEG analysis. The DEG-Seq Algorithm and edgeR software were used to analyze the differentially expressed genes between MCF-7/Scr and MCF-7/c-Abl/Argknockdown cells (fold change of case/control ³2 or £0.5, false discovery rate (FDR) <0.05)
Gene ontology and pathway analysis
Gene Ontology (GO) analysis was performed to identify the potential functions of the DEGs. By analyzing the genes with DAVID version 6.8 (https://david.ncifcrf.gov/), the biological process, molecular function, and cellular component functions were classified, and P-values were computed. The Kyoto Encyclopedia of Genes and Genomes (KEGG) was employed to determine the significant pathways in which the genes were involved. Fisher's exact test was used to identify significantly enriched pathways, and the P-value was set to define the threshold of significance. Significant pathway terms were indicated by a P-value £0.05, whereas non-significant pathway terms were indicated by a P-value >0.05. The smaller the P-value, the more specific the gene's function. This analysis can aid the identification of significant pathways involving DEGs. Quality control analysis by Fast-QC showed that the Q scores (from 1 to 100) of all reads were >28, indicating that high-quality RNA-Seq data had been obtained ( Figure 1B ). The reads per kilobase million reads (RPKM) values were less than 20 for ~75% of the reads that were mapped to genes, indicating that most of the genes in the libraries were expressed at low levels ( Figure 1C) . The read distribution analysis showed that the mapped reads were evenly distributed in the mRNA from the 5' to 3' ends ( Figure 1D ). Approximately 90% of the 69 million mapped reads mapped to exon coding sequences, and ~69.8% of the reads mapped to protein coding sequences ( Figure 1E ). Similar RNA-Seq data were obtained from the scrambled control cells (Figure 2 ). These results demonstrated that the RNA-Seq data were high quality and reliable, and therefore, these data were used for the following differential expression analysis.
c-Abl/Arg regulates gene transcription c-Abl has been reported to be involved in the regulation of gene transcription. To investigate transcription regulation by Abl kinases, the DEGs between the MCF-7/Scr and MCF-7/c-Abl/ Arg-knockdown cells were determined based on the RPKM values of all mapped genes. The correlation analysis showed that the expression levels of specific genes in the 2 samples from the MCF-7/Scr and MCF-7/c-Abl/Arg-knockdown cells were well correlated (R 2 =0.978) ( Figure 3A) , suggesting that the RNASeq data were highly repeatable. Using edgeR software, the DEGs were filtered using the following criteria: P£0.01 and fold change ³2 or £0.5. The results showed that 1,034 DEGs were significantly regulated by the Abl kinases, of which 635 were down-regulated and 399 were up-regulated in the c-Abl/Arg gene-silenced cells ( Figure 3B) . Furthermore, the significant regulation of mRNA transcription levels by c-Abl/Arg was verified by qRT-PCR ( Figure 3C ). The data for 60 genes significantly down-or up-regulated by c-Abl/Arg gene silencing are presented in Table 2 .
Functional analysis of the c-Abl/Arg-regulated DEGs
To further understand the potential cellular function and associated pathways of these DEGs, we performed GO term (including biological process, molecular function and cellular component) and KEGG pathway analyses. As shown by the biological process analysis, the functions of the genes that were downregulated by c-Abl/Arg gene silencing (i.e., genes positively regulated by the Abl kinase) were mainly involved in virus defense response (GO: 0051607, GO: 0060337 and GO: 0045071) and oxidoreductase-involved metabolic processes, including chemotherapeutic drugs (GO: 0044597 and GO: 0044598), progesterone (GO: 0042448), steroid (GO: 0008202), and fatty acid (GO: 0006631) metabolic processes ( Figure 4A ). Proteins with calcium-dependent phospholipid binding activity (GO: 0005544), oxidoreductase activity (GO: 0004032, GO: 0016491, GO: 0047718, GO0047086, etc.), and protein binding capacity (GO: 0005515) were the most enriched molecular functions ( Figure 4B ). Extracellular exosome (GO: 0070062), basement membrane (GO: 0005604), and cytosol (GO: 0005829) were the most enriched cellular components ( Figure 4C ). The KEGG analysis revealed that the greatest enrichments also occurred in metabolism regulation, such as the metabolism of porphyrin (hsa00860) and beta-alanine (hsa00410), pentose and glucuronate interconversions (hsa00040), the metabolism of xenobiotics by cytochrome P450 (hsa00980), and steroid hormone biosynthesis (hsa00140), etc. (Figure 4D ).
According to the biological process analysis, the genes that were up-regulated by c-Abl/Arg gene silencing (i.e., genes negatively regulated by the Abl kinase) were enriched in cAMP catabolic and signaling process (GO: 0006198 and GO: 0019933), positive regulation of transcription (GO: 0045944 and GO: 0045893), and positive regulation of cell proliferation (GO: 0048661 and GO: 0008284) ( Figure 5A ). cAMP phosphodiesterase activity (GO: 0004115, GO: 0004114, and GO: 0030552), metal ion binding (GO: 0046872 and GO: 0008270), actin binding (GO: 0003779), and DNA or chromatin binding (GO: 0000978, GO: 0001077, GO: 0043565, and GO: 0003682) were the most enriched molecular functions ( Figure 5B) . Moreover, the nucleus (GO: 0005634), neuronal cell body (GO: 0043025), and microtubule organizing center (GO: 0005815) were the most enriched cellular components ( Figure 5C ). The KEGG pathway analysis showed that signaling pathways in Parkinson's disease (hsa05012), signaling pathways in cancer (hsa05200), the cAMP signaling pathway (hsa04024), signaling pathways in insulin resistance (hsa04931), and the oxytocin signaling pathway (hsa04921) were the most enriched ( Figure 5D) . These data collectively demonstrate that c-Abl/Arg can positively or negatively regulate gene transcription to participate in metabolism, virus defense responses, cell proliferation, nervous system disease and tumorigenesis.
Discussion
The Abl family of protein tyrosine kinases, c-Abl and Arg, functions to link diverse stimuli, such as DNA damage, oxidative stress, Src tyrosine kinases, and growth factors, to signaling pathways controlling cell growth, survival, stress, invasion, adhesion, and migration. Mice with targeted disruption of the cabl gene are born runted, exhibit head and eye abnormalities, and succumb as neonates with defective lymphopoiesis [31, 32] . Moreover, embryos deficient in both c-abl and arg exhibit defects in neurulation and die by 11 days postcoitus [33] . These findings demonstrate that c-Abl and Arg play essential and overlapping roles in biological processes. In contrast to Arg, the C-terminus of c-Abl has a DNA binding domain and NLS, which allow c-Abl kinase to enter the nucleus and regulate gene transcription. Although c-Abl is involved in gene transcription by directly mediating the tyrosine phosphorylation of specific transcription factors or regulators, the global regulation of gene transcription by Abl kinases is unknown.
Because c-Abl and Arg have common and unique domains and thus exhibit overlapping as well as unique functions, the expression of both genes was simultaneously silenced by RNAi, and c-Abl/Arg-mediated transcription regulation was investigated by RNA-Seq. By comparing the differentially expressed genes between scrambled cells and MCF-7/c-Abl/ Arg-knockdown cells, we revealed that 1,034 DEGs were regulated by c-Abl/Arg, and several of these genes were validated by qRT-PCR ( Figure 3C ). To further understand their potential cellular functions, we employed GO and KEGG to analyze these DEGs. The genes down-regulated by c-Abl/Arg gene silencing were mainly enriched in oxidoreductase-involved metabolic processes (including chemotherapeutic drugs, progesterone, steroid, retinoic acid, and fatty acid) and the antivirus response (including type I interferon signaling pathway and virus replication), whereas the up-regulated genes were mainly enriched in cAMP metabolic processes and signaling membrane respiration chain complex subunits, such as ND1, ND4L, COX2, and ATP8, by c-Abl/Arg expression might participate in neurodegenerative disease. Notably, c-Abl/Arg regulates the transcription of not only nucleus-encoded but also mitochondrion-encoded genes (as mentioned above). DEGs regulated by c-Abl/Arg were also significantly enriched in chemotherapeutic drug metabolic processes (GO: 0044597 and GO: 0044598), consistent with several studies that have reported activation of c-Abl/Arg in cells in response to doxorubicin (DOX) treatment. For example, the data suggest that c-Abl kinase plays a vital role in DOX-induced NF-kB signaling, and inhibition of kinase activity leads to increased cellular sensitivity to the induction of apoptosis [35] . In response to DOX-induced DNA damage, c-Abl also acts upstream of DNA damage-activated signaling cascades via activation of the PI-3 kinase-like kinases Atm and Atr and thus has been implicated in controlling apoptosis, DNA repair and cell cycle progression [36] . Our finding identified that Abl kinase-regulated DEGs may be involved in the metabolic of doxorubicin, providing a potential mechanism by which Abl kinase responses to doxorubicin or other chemotherapeutic drug treatment.
Genes that were positively transcriptionally by c-Abl/Arg expression were also significantly enriched in metabolic pathways, which have seldom been studied in Abl kinase functions. A recent study found that c-Abl was activated in fumarate hydratase-deficient kidney tumors (hereditary leiomyomatosis and renal cell carcinoma, HLRCC), which are characterized by high glycolysis and accumulate high levels of fumarate, lactate and hypoxia-stimulated transcription factor (HIF1a) [37] . Activation of c-Abl in HLRCC functions to promote aerobic glycolysis through activation of mTOR-HIF1a. Consistent with this finding, our study demonstrated that aldo-keto reductase family 1 members (including AKR1C3, AKR1C2, AKR1B10, 
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